Figure 5From: Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series mHLA-DR expression in rIFN-γ treated patients, divided into immunoparalyzed patients with baseline HLA-DR expression below 50% (solid dots), and without HLA-DR defined immunoparalysis (open dots). Data are expressed as median [IQR].Back to article page